BZ
BZAIW
Blaize Holdings, Inc.
$0.2901
0.00%
$54.1M
No data for this timeframe.
Vol
Market Cap$54.1M
Cap SizeMicro Cap
Inst. Holders7 funds
Inst. Value$959.7K
Inst. Activity2 buys / 1 sells
SEC Reports4
Recent Activity
May 14, 2026
SEC
Blaize reported Q1 2026 revenue of $2.7M, up 172% YoY, in line with the preliminary estimate and consensus. Gross margin
8-K — Impact 5/10
May 6, 2026
SEC
Blaize Holdings priced a $35M underwritten public offering of 18,918,918 shares at $1.85/share, with a 30-day underwrite
8-K — Impact 7/10
Apr 22, 2026
SEC
Blaize Holdings, Inc. adopted a limited-duration shareholder rights plan to protect against unsolicited takeovers. The p
8-K — Impact 4/10
Inst.
Hudson Bay Capital Management — ADD
455,888 shares ($182.3K)
Inst.
WOLVERINE ASSET MANAGEMENT LLC — DOUBLED
402,909 shares ($161.1K)
Latest Reports
NEUTRAL
8-K
5/10
Blaize reported Q1 2026 revenue of $2.7M, up 172% YoY, in line with the preliminary estimate and consensus. Gross margin
May 14, 2026
BEARISH
8-K
7/10
Blaize Holdings priced a $35M underwritten public offering of 18,918,918 shares at $1.85/share, with a 30-day underwrite
May 6, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| D. E. Shaw & | $315.0K | — |
| LMR Partners LLP | $233.7K | — |
| Hudson Bay Capital Management | $159.5K | ADD |
| WOLVERINE ASSET MANAGEMENT LLC | $154.0K | DOUBLED |
| Clear Street Group Inc. | $76.5K | TRIM |
7 institutional holders with $959.7K total value (2,636,445 shares) as of 2026-Q1. Top holders: D., LMR, Hudson.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | D. E. Shaw & Co., Inc. | 900,000 | $315.0K | 32.8% | — |
| 2 | LMR Partners LLP | 615,000 | $233.7K | 24.4% | — |
| 3 | Hudson Bay Capital Management LP | 455,788 | $159.5K | 16.6% | ADD +37.7% |
| 4 | WOLVERINE ASSET MANAGEMENT LLC | 405,376 | $154.0K | 16.1% | DOUBLED +153.5% |
| 5 | Clear Street Group Inc. | 201,429 | $76.5K | 8.0% | TRIM -30.9% |
| 6 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 48,541 | $17.0K | 1.8% | — |
| 7 | GOLDMAN SACHS GROUP INC | 10,311 | $3.9K | 0.4% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| Hudson Bay Capital Management LP | ADD | 331,000 | 455,888 | +37.7% | $182.3K | 2025-Q4 |
| WOLVERINE ASSET MANAGEMENT LLC | DOUBLED | 158,928 | 402,909 | +153.5% | $161.1K | 2025-Q4 |
| Clear Street Group Inc. | TRIM | 291,429 | 201,429 | -30.9% | $80.6K | 2025-Q4 |
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
4 SEC filing reports analyzed. Sentiment: 0 bullish, 1 bearish, 1 mixed, 2 neutral. Avg impact: 5.5/10.
NEUTRAL
8-K
5/10
Blaize reported Q1 2026 revenue of $2.7M, up 172% YoY, in line with the preliminary estimate and con
May 14, 2026
BEARISH
8-K
7/10
Blaize Holdings priced a $35M underwritten public offering of 18,918,918 shares at $1.85/share, with
May 6, 2026
NEUTRAL
8-K
4/10
Blaize Holdings, Inc. adopted a limited-duration shareholder rights plan to protect against unsolici
Apr 22, 2026
MIXED
8-K
6/10
Blaize reported preliminary Q1 2026 revenue of $2.7 million, significantly below its $130 million an
Apr 21, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | 519.3% | — |
| Next Q 2026-09-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | 247.2% | — |
| Current FY 2026-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.1B | 222.1% | — |
| Next FY 2027-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.2B | 46.3% | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.